Zobrazeno 1 - 10
of 32
pro vyhledávání: '"Sara Belluco"'
Autor:
Nicolas Serratrice, Celine Ertlen, Sara Belluco, Joevin Sourdon, Virginie Callot, Jeremy Magalon, Florence Sabatier, Stephane Fuentes, Jean-Michel Brezun, Tanguy Marqueste, Patrick Decherchi
Publikováno v:
Brain and Spine, Vol 3, Iss , Pp 101839- (2023)
Externí odkaz:
https://doaj.org/article/2aaec8083f4c491694317836a2cb276f
Autor:
Mehrdad Khoshnevis, Richard Brown, Sara Belluco, Ilyes Zahi, Luca Maciocco, Catherine Bonnefont-Rebeix, Elodie Pillet-Michelland, Jonathan Tranel, Thierry Roger, Christophe Nennig, Patrick Oudoire, Lionel Marcon, Olivier Tillement, Cédric Louis, Hélène Gehan, Manuel Bardiès, Maurizio Mariani, Valeria Muzio, Jean-Philippe Meunier, Charlotte Duchemin, Nathalie Michel, Estelle N’Tsiba, Ferid Haddad, Thierry Buronfosse, Claude Carozzo, Frédérique Ponce
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
Glioblastoma is considered the most common malignant primary tumor of central nervous system. In spite of the current standard and multimodal treatment, the prognosis of glioblastoma is poor. For this reason, new therapeutic approaches need to be dev
Externí odkaz:
https://doaj.org/article/8aada16306dc42f0904f1ec20a17adaf
Autor:
Mehrdad Khoshnevis, Claude Carozzo, Richard Brown, Manuel Bardiès, Catherine Bonnefont-Rebeix, Sara Belluco, Christophe Nennig, Lionel Marcon, Olivier Tillement, Hélène Gehan, Cédric Louis, Ilyes Zahi, Thierry Buronfosse, Thierry Roger, Frédérique Ponce
Publikováno v:
PLoS ONE, Vol 15, Iss 6, p e0234772 (2020)
Glioblastoma is the most aggressive primary brain tumor leading to death in most of patients. It comprises almost 50-55% of all gliomas with an incidence rate of 2-3 per 100,000. Despite its rarity, overall mortality of glioblastoma is comparable to
Externí odkaz:
https://doaj.org/article/ca007830bfb549eba8364395c7172873
Autor:
Sara Belluco, Giuseppe Marano, Kerstin Baiker, Andreas Beineke, Anna Oevermann, Frauke Seehusen, Patrizia Boracchi, Marti Pumarola, Maria Teresa Mandara
Publikováno v:
Veterinary and Comparative Oncology. 20:509-520
The human grading system is currently applied to canine meningioma, although it has not been validated in dogs. The present study focused on standardising the human grading system applied to canine meningioma. Four veterinary neuropathologists graded
Autor:
Mehrdad, Khoshnevis, Richard, Brown, Sara, Belluco, Ilyes, Zahi, Luca, Maciocco, Catherine, Bonnefont-Rebeix, Elodie, Pillet-Michelland, Jonathan, Tranel, Thierry, Roger, Christophe, Nennig, Patrick, Oudoire, Lionel, Marcon, Olivier, Tillement, Cédric, Louis, Hélène, Gehan, Manuel, Bardiès, Maurizio, Mariani, Valeria, Muzio, Jean-Philippe, Meunier, Charlotte, Duchemin, Nathalie, Michel, Estelle, N'Tsiba, Ferid, Haddad, Thierry, Buronfosse, Claude, Carozzo, Frédérique, Ponce
Publikováno v:
Frontiers in oncology. 12
Glioblastoma is considered the most common malignant primary tumor of central nervous system. In spite of the current standard and multimodal treatment, the prognosis of glioblastoma is poor. For this reason, new therapeutic approaches need to be dev
Publikováno v:
Veterinary Pathology
Veterinary Pathology, SAGE Publications, 2020, 57 (5), pp.599-607. ⟨10.1177/0300985820941818⟩
Veterinary Pathology, SAGE Publications, 2020, 57 (5), pp.599-607. ⟨10.1177/0300985820941818⟩
Canine cutaneous histiocytoma (CCH) is a noninfectious tumor that spontaneously regresses. It is suggested that this regression is due to tumor cell maturation, which is responsible for CD8 lymphocyte activation and tumor cell destruction. Neverthele
Autor:
Cédric Louis, Lionel Marcon, Mehrdad Khoshnevis, Catherine Bonnefont-Rebeix, Frédérique Ponce, Thierry Buronfosse, T. Roger, Claude Carozzo, Richard Brown, Manuel Bardiès, Olivier Tillement, Hélène Gehan, Christophe Nennig, Sara Belluco, Ilyes Zahi
Publikováno v:
PLoS ONE
PLoS ONE, 2020, 15 (6), pp.e0234772. ⟨10.1371/journal.pone.0234772⟩
PLoS ONE, Public Library of Science, 2020, 15 (6), pp.e0234772. ⟨10.1371/journal.pone.0234772⟩
PLoS ONE, Vol 15, Iss 6, p e0234772 (2020)
PLoS ONE, 2020, 15 (6), pp.e0234772. ⟨10.1371/journal.pone.0234772⟩
PLoS ONE, Public Library of Science, 2020, 15 (6), pp.e0234772. ⟨10.1371/journal.pone.0234772⟩
PLoS ONE, Vol 15, Iss 6, p e0234772 (2020)
International audience; Glioblastoma is the most aggressive primary brain tumor leading to death in most of patients. It comprises almost 50-55% of all gliomas with an incidence rate of 2-3 per 100,000. Despite its rarity, overall mortality of gliobl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::128548ab9e9048f662cf158be98a0e6c
https://www.hal.inserm.fr/inserm-02907080/document
https://www.hal.inserm.fr/inserm-02907080/document
Autor:
Sara Belluco, Luc Chabanne, David Sayag, Frédérique Ponce, Benoit Rannou, E. Segard, T. Bouzouraa, J. L. Cadoré
Publikováno v:
Revue Vétérinaire Clinique
Summary A 2-year-old female domestic shorthair cat was referred with a 2 month history of lethargy, weight loss, recurrent hyperthermia and polyarthropathy despite prednisolone. Upon physical examination, the cat showed apathy, hyperthermia, multiple
Publikováno v:
Veterinary Pathology
Veterinary Pathology, SAGE Publications, 2019, 56 (3), pp.342-349. ⟨10.1177/0300985818824952⟩
Veterinary Pathology, SAGE Publications, 2019, 56 (3), pp.342-349. ⟨10.1177/0300985818824952⟩
In routine diagnostic activity, pathologists may be confronted with nervous system tumors. The lack of clinical information, economic restrictions for additional testing, and the lack of expertise in neuropathology may render the diagnosis challengin
Autor:
Sara Belluco, Frédérique Ponce, Elodie Pillet-Michelland, T. Roger, Olivia Leveneur, Matthieu Dreyfus, Mehrdad Khoshnevis, Claude Carozzo, Thomas Chuzel, François Berger, Catherine Bonnefont-Rebeix
Publikováno v:
Journal of neuroscience methods. 282
Background Glioblastoma is the most common and deadliest primary brain tumor for humans. Despite many efforts toward the improvement of therapeutic methods, prognosis is poor and the disease remains incurable with a median survival of 12–14.5 month